针对I期组合试验的以患者为中心的方法进入阶段
Alberto Hernando-Calvo1,2, Elena Garralda1,2
1Vall d'Hebron University Hospital, Barcelona, Spain.
Cancer discovery
|June 3, 2023
概括
一种新型药物PF-07284892在克服向癌症治疗的耐药性方面显示出有前途. 这种颠覆性的临床试验设计为其潜在的临床应用提供了概念证明.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 向疗法已经彻底改变了癌症治疗,但往往受到获得的抵抗机制的限制.
- 克服耐药性是临床瘤学中至关重要的未满足需求.
- 开发新型药物来规避这些抗药性途径对于改善患者的治疗结果至关重要.
研究的目的:
- 为了证明PF-07284892能够克服针对性治疗的耐药性机制的概念证明.
- 评估PF-07284892在耐药癌症患者中的临床潜力.
- 验证破坏性临床试验设计,以评估新型治疗策略.
主要方法:
- 使用了一种破坏性临床试验设计.
- 该研究的重点是PF-07284892.9的管理和评估.
- 收集了临床数据以评估疗效和概念验证.
主要成果:
- 该研究成功证明了PF-07284892.9的概念证明.
- PF-07284892在克服针对性治疗的耐药性机制方面显示出潜力.
- 破坏性试验设计在评估药物的潜力方面被证明是有效的.
结论:
- PF-07284892具有克服针对性癌症治疗的耐药性的巨大潜力.
- 这些发现支持PF-07284892.9的进一步临床开发.
- 创新的试验设计有助于快速评估新型治疗剂.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.1K
相关概念视频
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Drug Administration and Therapy Phases: Overview
564
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
564
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150
Drug Metabolism: Phase I Reactions
3.4K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.4K
